Investigator
Kurt Derek Christensen
HARVARD PILGRIM HEALTH CARE, INC. · funded by NICHD
- Companies
- 3
- Grants
- 4
- Non-dilutive funding
- $2.8M
- First award
- Sep 11, 2017
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 1, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- HARVARD PILGRIM HEALTH CARE, INC.Momentum in another area
Grant-only
- HARVARD PILGRIM HEALTH CARE, INC.35momentum
OncologyGrant-only
- HARVARD PILGRIM HEALTH CARE, INC.26momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Long-term Impact and Value of Infant Genomic Sequencing (LIVING)
$714kSep 1, 2024NICHDHARVARD PILGRIM HEALTH CARE, INC.NIH RePORTER · 11176797 (opens the source filing in a new tab)
- R01
Long-term Impact and Value of Infant Genomic Sequencing (LIVING)
$705kSep 1, 2024NICHDHARVARD PILGRIM HEALTH CARE, INC.NIH RePORTER · 11336311 (opens the source filing in a new tab)
- R01
Precision Medicine Policy and Treatment (PreEMPT) Model II
$686kSep 11, 2017NICHDHARVARD PILGRIM HEALTH CARE, INC.NIH RePORTER · 11040323 (opens the source filing in a new tab)
- R01
Precision Medicine Policy and Treatment (PreEMPT) Model II
$672kSep 11, 2017NICHDHARVARD PILGRIM HEALTH CARE, INC.NIH RePORTER · 11285269 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources